NCT02233023View on ClinicalTrials.gov

Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

705

Participants

Timeline

Start Date

June 30, 1998

Primary Completion Date

June 30, 2000

Conditions
Parkinson Disease
Interventions
DRUG

Pramipexole

DRUG

Bromocriptine and other dopamine agonists

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02233023 - Ophthalmologic Safety of Long Term Treatment With Pramipexole Compared to Bromocriptine or Other Dopamine Agonists in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter